This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Cruzain

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
Cru inhibitors are being investigated for therapeutic use against Chagas disease.
Cru inhibitors are being investigated for therapeutic use against Chagas disease.
 +
 +
== Structural highlights ==
 +
 +
Cru catalytic triad is Cys-His-Asn.
</StructureSection>
</StructureSection>

Revision as of 11:30, 15 December 2015

Structure of cruzain catalytic domain complex with methylketone inhibitor (PDB entry 1me3)

Drag the structure with the mouse to rotate

3D structures of cruzain

Updated on 15-December-2015

1aim, 2aim, 1me3, 1me4 – Cru catalytic domain + methylketone inhibitor – Trypanosoma cruzi
1f29, 1f2a, 1f2b, 1f2c, 1ewo, 3lxs - Cru catalytic domain + vinyl sulfone derived inhibitor
1ewl, 1ewm – Cru catalytic domain + methylbutane inhibitor
1ewp - Cru catalytic domain + MOR-Leu-HPQ

References

  1. ↑ Brinen LS, Hansell E, Cheng J, Roush WR, McKerrow JH, Fletterick RJ. A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease. Structure. 2000 Aug 15;8(8):831-40. PMID:10997902

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Cruzain"
Personal tools